Tech Company Financing Transactions
Molecular Detection Funding Round
On 10/1/2009, Molecular Detection received $3.3 million in Series C funding from MentorTech Ventures, Mid-Atlantic Angel Group and Robin Hood Ventures.
Transaction Overview
Company Name
Announced On
10/1/2009
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 East Lancaster Ave. 300
Wayne, PA 19087
USA
Wayne, PA 19087
USA
Phone
Website
Email Address
Overview
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of sample-to-answer Detect-Ready molecular diagnostic tests for the rapid detection of infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Wallach
Chief Financial Officer
Robert Citron
President
Aryeh Gassel
VP - Manufacturing
Fredi Kleinman
VP - Operations
David Wilson
VP - R & D
Tzvi Tzubery
VP - Regulatory Affairs
Avraham Harris
Browse more venture capital transactions:
Prev: 10/1/2009: Adimab venture capital transaction
Next: 10/1/2009: Techniscan Medical Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs